LYMPHOPROLIFERATIVE SYNDROME 3
|
disease |
|
Disease or Syndrome
|
2
|
3
|
0.410 |
None |
1.000 |
3 |
3
|
2017 |
2017 |
EBV-Related Malignant Neoplasm
|
disease |
|
Neoplastic Process
|
1
|
|
0.300 |
strong |
1.000 |
1 |
|
2017 |
2017 |
Combined immunodeficiency
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases; Immune System Diseases
|
Disease or Syndrome
|
86
|
11
|
0.300 |
strong |
1.000 |
1 |
|
2017 |
2017 |
Lupus Erythematosus, Systemic
|
disease |
Skin and Connective Tissue Diseases; Immune System Diseases
|
Disease or Syndrome
|
1883
|
1172
|
0.100 |
None |
0.952 |
21 |
|
2004 |
2019 |
Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
10161
|
1644
|
0.100 |
None |
0.938 |
16 |
|
1998 |
2020 |
Malignant Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
8621
|
1641
|
0.100 |
None |
1.000 |
10 |
|
2017 |
2020 |
Lymphoproliferative Disorders
|
group |
Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
300
|
14
|
0.100 |
None |
|
0 |
|
|
|
Variable expressivity
|
phenotype |
|
Finding
|
319
|
|
0.100 |
None |
|
0 |
|
|
|
Lymphadenopathy
|
phenotype |
Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
277
|
5
|
0.100 |
None |
|
0 |
|
|
|
Decreased antibody level in blood
|
phenotype |
|
Finding
|
75
|
5
|
0.100 |
None |
|
0 |
|
|
|
Hepatomegaly
|
phenotype |
Pathological Conditions, Signs and Symptoms; Digestive System Diseases
|
Finding
|
523
|
30
|
0.100 |
None |
|
0 |
|
|
|
Lupus Vulgaris
|
disease |
Infections; Skin and Connective Tissue Diseases
|
Disease or Syndrome
|
526
|
44
|
0.090 |
None |
1.000 |
9 |
|
2004 |
2011 |
Lupus Erythematosus, Discoid
|
disease |
Skin and Connective Tissue Diseases
|
Disease or Syndrome
|
552
|
46
|
0.090 |
None |
1.000 |
9 |
|
2004 |
2011 |
Lupus Erythematosus
|
disease |
Pathological Conditions, Signs and Symptoms; Skin and Connective Tissue Diseases; Immune System Diseases
|
Disease or Syndrome
|
558
|
44
|
0.090 |
None |
1.000 |
9 |
|
2004 |
2011 |
Renal Cell Carcinoma
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Neoplastic Process
|
2084
|
288
|
0.060 |
None |
1.000 |
6 |
|
2006 |
2019 |
Conventional (Clear Cell) Renal Cell Carcinoma
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Neoplastic Process
|
2346
|
222
|
0.060 |
None |
1.000 |
6 |
|
2006 |
2019 |
Lymphoma, Non-Hodgkin
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
733
|
197
|
0.050 |
None |
1.000 |
5 |
1
|
2007 |
2019 |
Primary malignant neoplasm
|
group |
Neoplasms
|
Neoplastic Process
|
8221
|
1374
|
0.050 |
None |
1.000 |
5 |
|
2017 |
2018 |
Lymphoma
|
group |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
1548
|
91
|
0.050 |
None |
1.000 |
5 |
|
2000 |
2019 |
Glioma
|
disease |
Neoplasms
|
Neoplastic Process
|
3097
|
353
|
0.040 |
None |
1.000 |
4 |
|
2002 |
2018 |
Glioblastoma
|
disease |
Neoplasms
|
Neoplastic Process
|
3177
|
281
|
0.040 |
None |
1.000 |
4 |
|
2002 |
2018 |
Epstein-Barr Virus Infections
|
group |
Infections
|
Disease or Syndrome
|
384
|
72
|
0.040 |
None |
1.000 |
4 |
|
1998 |
2018 |
Malignant neoplasm of breast
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
6941
|
3417
|
0.030 |
None |
1.000 |
3 |
2
|
2010 |
2018 |
melanoma
|
disease |
Neoplasms
|
Neoplastic Process
|
3087
|
515
|
0.030 |
None |
0.667 |
3 |
|
2001 |
2016 |
Childhood Lymphoma
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
1171
|
66
|
0.030 |
None |
1.000 |
3 |
|
2005 |
2019 |